Anacor Pharmaceuticals, Inc. Watch

EX-10.4

from 8-K 31 pages To: Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto, Ca 94303 a/C: [ ] From: Goldman, Sachs & Co. Re: Additional Capped Call Transaction Ref. No: [ ] Date: April 1, 2016 Dear Ladies and Gentlemen

12/34/56

EX-10.3

from 8-K 31 pages The Purpose of This Communication (This “Confirmation”) Is to Set Forth the Terms and Conditions of the Above-Referenced Transaction Entered Into on the Trade Date Specified Below (The “Transaction”) Between Citigroup Global Markets Inc. (“Dealer”) and Anacor Pharmaceuticals, Inc. (“Counterparty”). This Communication Constitutes a “Confirmation” as Referred to in the Isda Master Agreement Specified Below

12/34/56

EX-10.2

from 8-K 30 pages To: Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto, Ca 94303 a/C: [ ] From: Goldman, Sachs & Co. Re: Base Capped Call Transaction Ref. No: [ ] Date: March 31, 2016 Dear Ladies and Gentlemen

12/34/56

EX-10.1

from 8-K 30 pages To: Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto, Ca 94303 From: Citigroup Global Markets Inc. Re: Base Capped Call Transaction Date: March 31, 2016 Dear Ladies and Gentlemen

12/34/56

EX-10.10

from 10-Q 3 pages Amendment No. 1 to the Manufacturing Agreement

12/34/56

EX-10.9

from 10-Q 6 pages Amendment to the Distribution and Commercialization Agreement

12/34/56

EX-10.8

from 10-Q 4 pages Consulting Agreement

12/34/56

EX-10.7

from 10-Q 10 pages May 31, 2015 Personal and Confidential Geoff Parker Re: Separation and Release Agreement

12/34/56

EX-10.6

from 10-Q 4 pages May 15, 2015 Graeme Bell Re: Offer of Employment by Anacor Pharmaceuticals, Inc. (The “Offer Letter”) May 15, 2015 Graeme Bell

12/34/56

EX-10.5

from 10-Q 4 pages April 29, 2015 Vince Ippolito Re: Amended and Restated Offer of Employment by Anacor Pharmaceuticals, Inc

12/34/56

EX-10.4

from 10-Q 4 pages April 9, 2014 Ryan Sullivan Re: Offer of Employment by Anacor Pharmaceuticals, Inc

12/34/56

EX-10.3

from 10-Q 7 pages Notice of Grant of Time-Vesting Restricted Stock Units (Director, Deferred Settlement) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Award Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.2

from 10-Q 7 pages Notice of Grant of Time-Vesting Restricted Stock Units (Director, Settlement Upon Vesting) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Award Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.1

from 10-Q 8 pages Notice of Grant of Time-Vesting Stock Options (Director) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Option Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.2

from 10-Q 4 pages Anacor Pharmaceuticals, Inc. 2010 Equity Incentive Plan Binding Notice of Amendment to Outstanding Stock Option, Restricted Stock and Restricted Stock Unit Awards February 3, 2015

12/34/56

EX-10.39

from 10-K 9 pages Notice of Grant of Performance-Vesting Restricted Stock Units (Employee) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Award Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.38

from 10-K 9 pages Notice of Grant of Time-Vesting Restricted Stock Units (Employee) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Award Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.37

from 10-K 9 pages Notice of Grant of Time-Vesting Stock Options (Employee) Anacor Pharmaceuticals, Inc. Id: [·] 1020 East Meadow Circle Palo Alto, Ca 94303 [Name of Participant] [Address] [City, State, Zip] Option Number: [·] Plan: [·] Id: [·]

12/34/56

EX-10.11

from 10-K ~1 page Amendment 4 to Anacor Pharmaceuticals, Inc. Advisory Board Agreement

12/34/56

EX-10.1

from 8-K 4 pages Sixth Amendment to Lease

12/34/56